XLO XILIO THERAPEUTICS INC Management Changes 8-K Filing 2023 - Annual Meeting of Stockholders Xilio Therapeutics held its 2023 annual meeting of stockholders where directors were elected and the selection of Ernst & Young LLP as the independent registered public accounting firm was ratified.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC